The importance of elucidating the right biomarkers in phase I oncology trials
Timothy Yap • 16 Apr 2023
Challenges associated with synthetic lethality in cancer therapeutics
Timothy Yap • 10 Sep 2022
Breast cancer patients with germline BRCA mutations: can we preserve fertility?